title: [Assessment of efficacy of thrombolytic therapy in the treatment and prognosis of myocardial infarction].
abstract: An apparent benefit has been shown to occur in acute myocardial infarction from the thrombolytic and antiaggregation therapy, that was evidenced by the absence of early post-infarction angina pectoris, decline in the incidence of disturbances of the heart's rhythm and conductivity, shortening of the hospital stay.
authors.forename: L P
authors.initials: LP
authors.lastname: Soleĭko
authors.forename: V P
authors.initials: VP
authors.lastname: Bashinskaia
authors.forename: E V
authors.initials: EV
authors.lastname: Soleĭko
authors.forename: N A
authors.initials: NA
authors.lastname: Balabaeva
authors.forename: L I
authors.initials: LI
authors.lastname: Ganskaia
authors.forename: V I
authors.initials: VI
authors.lastname: Psiuk
authors.forename: V Iu
authors.initials: VIu
authors.lastname: Maslovskiĭ
mesh_terms: D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000503:physiopathology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011379:Prognosis; D015912:Thrombolytic Therapy / Q000009:adverse effects
chemical_list: D010975:Platelet Aggregation Inhibitors